Aug 2, 2018 CGRP Inhibitor Erenumab Gains EU Approval for Migraine Prevention CGRP Inhibitor Erenumab Gains EU Approval for Migraine PreventionIt is a painful, highly disruptive neurological disease that affects all aspects of life, from going to work to spending time with family and friends,” said ... read morePublished on 2018-08-02